☆ 4.6 Article

Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2022)

Related references

Note: Only part of the references are listed.

Article Cardiac & Cardiovascular Systems

Identification of anticancer drugs associated with atrial fibrillation: analysis of the WHO pharmacovigilance database

Joachim Alexandre et al.

Summary: The emergence of novel anticancer therapies has led to signals of cardiotoxicity, including atrial fibrillation (AF), but data on the liability of anticancer drugs in inducing AF are scarce. A study using the World Health Organization's individual case safety report database, VigiBase(R), identified 19 anticancer drugs significantly associated with AF, with further confirmation needed through dedicated prospective clinical trials. The findings suggest that anticancer drugs themselves could be independent risk factors for AF development, particularly in hematologic malignancies.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)

Add to Collection

Article Oncology

Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer

Steven Deitelzweig et al.

Summary: This study found that among patients with nonvalvular atrial fibrillation and concurrent cancer, apixaban was associated with lower risk of stroke/systemic embolism and major bleeding compared to warfarin, while dabigatran and rivaroxaban had similar risks. There were variations in risk among different NOACs, but consistent treatment effects were seen across different types of cancer.

JACC: CARDIOONCOLOGY (2021)

Add to Collection

Article Oncology

Risk of Atrial Fibrillation According to Cancer Type A Nationwide Population-Based Study

Jun Pil Yun et al.

Summary: Patients with cancer have an increased risk of atrial fibrillation (AF), but the impact on AF development varies by cancer type.

JACC: CARDIOONCOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

Marco Proietti et al.

Summary: In European AF patients, three main clusters were identified, differentiated by the presence of comorbidities. Both non-cardiac and cardiac comorbidities clusters were associated with an increased risk of major adverse outcomes.

BMC MEDICINE (2021)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Anticoagulation for atrial fibrillation in active cancer: what the cardiologists think

Dimitrios Farmakis

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)

Add to Collection

Article Oncology

Thromboembolism, mortality, and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: A nationwide cohort study

Daniele Pastori et al.

Summary: This study investigated the impact of cancer on clinical outcomes in atrial fibrillation (AF) patients, as well as the performance of HAS-BLED and CHA(2)DS(2)-VASc scores. The results showed that cancer increased all-cause mortality, major bleeding, and intracranial hemorrhage risk in AF patients. The risk of ischemic stroke varied among different cancer types, with some showing higher bleeding risk compared to thromboembolic risk.

CANCER (2021)

Add to Collection

Review Cardiac & Cardiovascular Systems

Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atria fibrillation severity, risk and outcomes

Giuseppe Boriani et al.

Summary: Atrial fibrillation presents in various patterns and is associated with an increased risk of stroke, which is related to the duration of AF episodes. Monitoring AF burden and understanding factors that condition AF susceptibility are important for managing the disease and predicting adverse outcomes.

CARDIOVASCULAR RESEARCH (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Jan Steffel et al.

EUROPACE (2021)

Add to Collection

Review Medicine, General & Internal

Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology

Giuseppe Boriani et al.

Summary: The latest ESC guidelines on AF focus on improving detailed characterization and management of patients, suggesting a comprehensive approach for practitioners rather than simply prescribing oral anticoagulation or deciding on a rhythm or rate control strategy.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2021)

Add to Collection

Article Clinical Neurology

Clinical Outcomes in Atrial Fibrillation Patients With a History of Cancer Treated With Non-Vitamin K Antagonist Oral Anticoagulants A Nationwide Cohort Study

Yi-Hsin Chan et al.

Summary: This study found that in patients with atrial fibrillation and cancer, NOACs have a lower risk of major adverse cardiovascular events, major adverse limb events, venous thrombosis, and major bleeding compared to warfarin. The results support the consideration of thromboprophylaxis with NOACs instead of warfarin for this patient population.

STROKE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Anticoagulation in patients with atrial fibrillation and active cancer: an international survey on patient management

Giuseppe Boriani et al.

Summary: The survey highlights the challenges in managing anticoagulation in patients with AF and active cancer, with substantial heterogeneity in therapeutic choices. Despite the emerging role of DOACs, the substantial use of LMWH continues, despite the lack of long-term data on thromboprophylaxis in AF.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)

Add to Collection

Article Hematology

Efficacy and Safety of Nonvitamin K Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer: A Study-Level Meta-Analysis

Ilaria Cavallari et al.

THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Article Oncology

Are Patients with Active Cancer and Those with History of Cancer Carrying the Same Risks of Recurrent VTE and Bleeding While on Anticoagulants?

Corinne Frere et al.

CANCERS (2020)

Add to Collection

Article Medicine, General & Internal

Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer

Giancarlo Agnelli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Medicine, General & Internal

The Euro Heart Survey and EURObservational Research Programme (EORP) in atrial fibrillation registries: contribution to epidemiology, clinical management and therapy of atrial fibrillation patients over the last 20 years

Marco Vitolo et al.

INTERNAL AND EMERGENCY MEDICINE (2020)

Add to Collection

Review Oncology

Direct Oral Anticoagulants in Patients With Active Cancer A Systematic Review and Meta-Analysis

Jolanda Sabatino et al.

JACC: CARDIOONCOLOGY (2020)

Add to Collection

Review Hematology

Atrial fibrillation and cancer - An unexplored field in cardiovascular oncology

Gordon Chu et al.

BLOOD REVIEWS (2019)

Add to Collection

Review Cardiac & Cardiovascular Systems

Anticoagulation Strategies in Patients With Cancer JACC Review Topic of the Week

Ramya C. Mosarla et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

Add to Collection

Review Cardiac & Cardiovascular Systems

Association of Cancer and the Risk of Developing Atrial Fibrillation: A Systematic Review and Meta-Analysis

Ming Yuan et al.

CARDIOLOGY RESEARCH AND PRACTICE (2019)

Add to Collection

Article Medicine, General & Internal

Atrial fibrillation in patients with active malignancy and use of anticoagulants: Under-prescription but no adverse impact on all-cause mortality

Vincenzo Livio Malavasi et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKETAF

Sean T. Chen et al.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry

Giuseppe Boriani et al.

EUROPACE (2018)

Add to Collection

Review Oncology

Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding

Giuseppe Boriani et al.

HEMATOLOGICAL ONCOLOGY (2018)

Add to Collection

Article Hematology

Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH

A. A. Khorana et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)

Add to Collection

Article Hematology

Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation

Surbhi Shah et al.

BLOOD ADVANCES (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry

Chiara Melloni et al.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2017)

Add to Collection

Article Medicine, General & Internal

Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial

Chiara Melloni et al.

AMERICAN JOURNAL OF MEDICINE (2017)

Add to Collection

Article Cardiac & Cardiovascular Systems

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

Jose Luis Zamorano et al.

EUROPEAN HEART JOURNAL (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Paulus Kirchhof et al.

EUROPEAN HEART JOURNAL (2016)

Add to Collection

Article Hematology

The impact of new-onset cancer among veterans who are receiving warfarin for atrial fibrillation and venous thromboembolism

D. B. Ambrus et al.

THROMBOSIS RESEARCH (2016)

Add to Collection

Review Cardiac & Cardiovascular Systems

Insights Into Onco-Cardiology Atrial Fibrillation in Cancer

Dimitrios Farmakis et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

Add to Collection

Article Hematology

Bleeding complications during anticoagulant treatment in patients with cancer

Pieter W. Kamphuisen et al.

THROMBOSIS RESEARCH (2014)

Add to Collection

Article Critical Care Medicine

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey

Ron Pisters et al.

CHEST (2010)

Add to Collection

Article Critical Care Medicine

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation

Gregory Y. H. Lip et al.

CHEST (2010)

Add to Collection

Review Medicine, General & Internal

A catalogue of reporting guidelines for health research

I. Simera et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)

Add to Collection

Article Medicine, General & Internal

A New Equation to Estimate Glomerular Filtration Rate

Andrew S. Levey et al.

ANNALS OF INTERNAL MEDICINE (2009)

Add to Collection

Article Oncology

Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: A retrospective analysis

BA Hutten et al.

JOURNAL OF CLINICAL ONCOLOGY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.